Literature DB >> 8127705

Activation of cAMP-dependent protein kinase alters the chromatin structure of the urokinase-type plasminogen activator gene promoter.

J S Lee1, L Catanzariti, B A Hemmings, B Kiefer, Y Nagamine.   

Abstract

In LLC-PK1 cells, the urokinase-type plasminogen activator (uPA) gene is induced by two of the major signal transduction pathways, the protein kinase C (PKC) and the cAMP-dependent protein kinase (PKA) pathways. We have analyzed the chromatin structure of 26 kb of the uPA gene locus and have shown that PKA activation but not PKC activation induce major chromatin structural alterations in the uPA gene promoter. In uninduced cells, several DNase I hypersensitive (HS) sites were detected in the 5' and 3' flanking regions but not in the transcribed region. Two of the sites correspond to previously characterized regulatory sites: a cAMP responsive site at nucleotide position -3500 with respect to the initiation site, and the PEA3/AP1 site at -2100 that mediates PKC activation. After the activation of PKA but not PKC, a strong HS site was induced at -2600. Functional analysis of this region revealed cAMP responsive activity. Chromatin structural alterations again brought about specifically by PKA but not by PKC were were also detected in the upstream of the promoter by topoisomerase I cleavage site analysis, with two prominent sites appearing at -2800 and -3300. These results suggest that the strong cAMP induction of the uPA gene requires structural alterations that permit cooperative interactions between the multiple cAMP responsive sites.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8127705      PMCID: PMC307845          DOI: 10.1093/nar/22.4.569

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  30 in total

Review 1.  DNA topoisomerases: enzymes that control DNA conformation.

Authors:  H P Vosberg
Journal:  Curr Top Microbiol Immunol       Date:  1985       Impact factor: 4.291

Review 2.  DNA topoisomerases.

Authors:  J C Wang
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

Review 3.  Plasminogen activators, tissue degradation, and cancer.

Authors:  K Danø; P A Andreasen; J Grøndahl-Hansen; P Kristensen; L S Nielsen; L Skriver
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

4.  Reversible and persistent changes in chromatin structure accompany activation of a glucocorticoid-dependent enhancer element.

Authors:  K S Zaret; K R Yamamoto
Journal:  Cell       Date:  1984-08       Impact factor: 41.582

5.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

6.  Hormonal regulation of plasminogen activator mRNA production in porcine kidney cells.

Authors:  Y Nagamine; M Sudol; E Reich
Journal:  Cell       Date:  1983-04       Impact factor: 41.582

7.  Temperature-sensitive changes in the structure of globin chromatin in lines of red cell precursors transformed by ts-AEV.

Authors:  H Weintraub; H Beug; M Groudine; T Graf
Journal:  Cell       Date:  1982-04       Impact factor: 41.582

8.  Assembly of an active chromatin structure during replication.

Authors:  H Weintraub
Journal:  Nucleic Acids Res       Date:  1979-10-10       Impact factor: 16.971

9.  Cytoskeletal reorganization and TPA differently modify AP-1 to induce the urokinase-type plasminogen activator gene in LLC-PK1 cells.

Authors:  J S Lee; D von der Ahe; B Kiefer; Y Nagamine
Journal:  Nucleic Acids Res       Date:  1993-07-25       Impact factor: 16.971

10.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.